Bioengineering Pancreatic Organoids and iPSC-Derived β-Cells for Diabetes: Materials, Devices, and Translational Challenges
Diabetes mellitus is primarily caused by the loss or malfunction of insulin-producing β-cells, and although current therapies improve glycemic control, they do not restore physiologic insulin secretion. Advances in stem cell biology and organoid engineering have led to the development of pancreatic...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2026-04-01
|
| Серія: | Bioengineering |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2306-5354/13/4/478 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
